Vermont could be the next state to change it's current marijuana laws. Vermont Governor Phil Scott planning to sign a bill to legalize marijuana for those 21 years or older. This will make Vermont the first state to do so through legislation. Montpelier, Vermont Mayor John Hollar explains how this could impact the growing market.
"People generally think its an inevitability in our state that we will have a legalization," says Hollar. "I think people understand and recognize that its going to happen."
Attorney General Jeff Sessions recently released a memo cracking down on the marijuana, reversing Obama era rules around how the market is treated at the federal versus state level. "I think it is a horrible policy decision," said Hollar. "I think it is an appalling use of federal crime resources to be chasing marijuana use."
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
